Fully Funded PhD: Drug Discovery Tech (Phage Display)

The Phage; Leeds; On-site; GBP 18,000 - 25,000; Full time

Benefits offered by this job

Tuition fees covered

Stipend provided (£21,805 for 2026/27)

Industry collaboration

Job summary

The Phage in collaboration with the University of Leeds invites applications for a fully funded PhD scholarship in Molecular and Cellular Biology, combining phage display, protein engineering and drug discovery.

The project aims to identify druggable pockets on target proteins, develop experimental methods, and work with industry partners to translate research into therapeutic technologies.

Qualifications

• Undergraduate degree with at least a 2:1 in a relevant subject.
• Backgrounds may include Biochemistry, Molecular Biology, Biotechnology etc.
• Master’s degree is desirable but not essential.
• Strong interest in drug discovery and protein science.

Responsibilities

• Develop and optimise experimental methods for drug discovery.
• Work with phage display and protein engineering technologies.
• Investigate therapeutic protein targets and potential druggable sites.
• Design and conduct molecular and biochemical experiments.
• Analyse and interpret experimental data.
• Develop new techniques and workflows to support drug discovery.
• Contribute to research conducted in collaboration with an industry partner.
• Maintain accurate experimental records and research documentation.
• Present research findings to academic and industry audiences.
• Contribute to scientific publications and research outputs.
• Participate in relevant training and activities within the School of Molecular and Cellular Biology.

Skills

Phage display

Protein engineering

Molecular biology

Education

2:1 degree in Biochemistry/Molecular Biology or related life sciences

Job description

The Phage in collaboration with the University of Leeds invites applications for a fully funded PhD scholarship in Molecular and Cellular Biology, combining phage display, protein engineering and drug discovery.

The project aims to identify druggable pockets on target proteins, develop experimental methods, and work with industry partners to translate research into therapeutic technologies.